SMTL ID : 5zj2.1

Crystal structure of NDM-1 in complex with D-captopril

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.10 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: D.96, C.180, H.222 Ligands: ZN.2, MCO.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.96, A:C.180, A:H.222 ZN.2: 5 residues within 4Å: Chain A: H.92, H.94, H.161 Ligands: ZN.1, MCO.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.92, A:H.94, A:H.161

1 x MCO: 1-(3-MERCAPTO-2-METHYL-PROPIONYL)-PYRROLIDINE-2-CARBOXYLIC ACID(Non-covalent)

MCO.3: 13 residues within 4Å: Chain A: M.39, F.42, V.45, W.65, H.94, D.96, H.161, C.180, G.191, N.192, H.222 Ligands: ZN.1, ZN.2 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:F.42, A:V.45, A:W.65 Hydrogen bonds: A:N.192 Salt bridges: A:K.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, G. et al., Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Bioorg.Med.Chem. (2020)

Release Date

2019-03-20

Peptides

Metallo-beta-lactamase type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Metallo-beta-lactamase type 2

Related Entries With Identical Sequence